Real-World PD-L1 Expression in Lung Cancer and its Correlation with Driver Mutations

被引：0
|
作者：
Wang, T. [1 ]
Xiao, S. [1 ]
Zhao, L. [1 ]
Chai, T. [1 ]
Fang, X. [1 ]
Lin, R. [1 ]
Li, T. [1 ]
机构：
[1] Hangzhou Repugene Technol Co Ltd, Hangzhou, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
PD-L1; Driver mutation;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P37.23
引用
收藏
页码：S452 / S452
页数：1
相关论文
共 50 条
  • [21] Association between PD-L1 expression and driver gene mutations in non-small cell lung cancer patients: correlation with clinical data
    Eleni A. Karatrasoglou
    Ilenia Chatziandreou
    Stratigoula Sakellariou
    Konstantinos Stamopoulos
    Nikolaos Kavantzas
    Andreas C. Lazaris
    Penelope Korkolopoulou
    Angelica A. Saetta
    Virchows Archiv, 2020, 477 : 207 - 217
  • [22] Association between PD-L1 expression and driver gene mutations in non-small cell lung cancer patients: correlation with clinical data
    Karatrasoglou, Eleni A.
    Chatziandreou, Ilenia
    Sakellariou, Stratigoula
    Stamopoulos, Konstantinos
    Kavantzas, Nikolaos
    Lazaris, Andreas C.
    Korkolopoulou, Penelope
    Saetta, Angelica A.
    VIRCHOWS ARCHIV, 2020, 477 (02) : 207 - 217
  • [23] The landscape of PD-L1 expression in lung cancer harboring EGFR mutations.
    Zhang, Linlin
    Gong, Fuyu
    Meng, Fanlu
    Wang, Xin
    Zhong, DianSheng
    CANCER RESEARCH, 2021, 81 (13)
  • [24] Investigating targeted driver mutations and PD-L1 expression for improved therapy of non-small cell lung cancer
    Alwithenani, Akram
    Forsythe, Marika
    Castonguay, Mathieu
    Greer, Wenda
    Flowerdew, Gorden
    Bethune, Drew
    Henteleff, Harry
    Plourde, Madelaine
    Mujoomdar, Aneil
    French, Daniel
    Johnston, Micheal
    Marcato, Paola
    Xu, Zhaolin
    CLINICAL CANCER RESEARCH, 2018, 24 (17)
  • [25] Driver Mutation Analysis and PD-L1 Expression in Synchronous Double Primary Lung Cancer
    Jia, Xiaoli
    Zhang, Liping
    Wu, Wei
    Zhang, Wei
    Wu, Chunyan
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2018, 26 (04) : 246 - 253
  • [26] EGFR Mutations and PD-L1 Expression in Early-Stage Non-Small Cell Lung Cancer: A Real-World Data From a Single Center in Brazil
    Pinto, Icaro Alves
    Cavagna, Rodrigo de Oliveira
    Virginio da Silva, Aline Larissa
    Dias, Josiane Mourao
    Santana, Iara Vidigal
    Souza, Laisa Caroline
    Ferreira da Silva, Flavio Augusto
    Biazotto Fernandes, Maria Fernanda
    Junqueira Pinto, Gustavo Dix
    Negreiros, Izabella Santos
    Santiago Goncalves, Maria Fernanda
    de Paula, Flavia Escremim
    Berardinelli, Gustavo Noriz
    Stanfoca Casagrande, Giovanna Maria
    da Silva, Marcela Oliveira
    Albino da Silva, Eduardo Caetano
    de Oliveira, Marco Antonio
    Jacinto, Alexandre Arthur
    da Silva, Vinicius Duval
    Reis, Rui Manuel
    De Marchi, Pedro
    Leal, Leticia Ferro
    ONCOLOGIST, 2022, 27 (11): : E899 - E907
  • [27] Real-World Prevalence of PD-L1 Expression Among Tumor Samples From Patients With Non-Small-Cell Lung Cancer
    Gelatti, Ana C. Z.
    Cordeiro de Lima, Vladmir C.
    Freitas, Helano
    Werutsky, Gustavo
    Gaiger, Ana Maria
    Klock, Clovis
    Viola, Patricia P.
    Shiang, Christina
    de Macedo, Mariana P.
    Lopes, Lisandro F.
    De Marchi, Pedro
    Albino da Silva, Eduardo Caetano
    Moura, Fernando
    Borges, Giuliano
    Zaffaroni, Facundo
    Nunes Filho, Paulo Ricardo
    Araujo, Luiz H.
    Mascarenhas, Eldsamira
    Mathias, Clarissa
    Barrios, Carlos
    Zukin, Mauro
    CLINICAL LUNG CANCER, 2020, 21 (06) : E511 - E515
  • [28] Real-world prospective data of small biopsy samples for tumor PD-L1 expression in non-small cell lung cancer
    Morikawa, K.
    Tsunoda, A.
    Inoue, T.
    Mineshita, M.
    ANNALS OF ONCOLOGY, 2018, 29
  • [29] Real-world outcomes in extensive-stage small cell lung cancer with PD-L1 inhibitors in China
    Meng, X.
    Peng, J.
    Li, S.
    Feng, H.
    Meng, R.
    Zhang, L.
    Liu, X.
    Yu, J.
    ANNALS OF ONCOLOGY, 2021, 32 : S1420 - S1421
  • [30] A Chinese multicenter, real-world study of PD-L1 inhibitors in extensive stage small cell lung cancer
    Peng, J.
    Meng, R.
    Liu, X.
    Zhang, L.
    Wang, L.
    Feng, R.
    Feng, H.
    Huang, Z.
    Yao, D.
    Li, X.
    Liu, N.
    Tan, B.
    Li, S.
    Yu, J.
    Meng, X.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S135 - S135
12345